Dr Reddys Laboratories (RDY) Total Current Liabilities: 2018-2025
- Dr Reddys Laboratories' Total Current Liabilities rose 32.55% to $1.5 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $1.5 billion, marking a year-over-year increase of 32.55%. This contributed to the annual value of $1.5 billion for FY2025, which is 32.55% up from last year.
- Latest data reveals that Dr Reddys Laboratories reported Total Current Liabilities of $1.5 billion as of Q1 2025, which was up 32.55% from $1.2 billion recorded in Q1 2024.
- In the past 5 years, Dr Reddys Laboratories' Total Current Liabilities ranged from a high of $1.5 billion in Q1 2025 and a low of $1.0 billion during Q1 2023.
- For the 3-year period, Dr Reddys Laboratories' Total Current Liabilities averaged around $1.2 billion, with its median value being $1.2 billion (2024).
- Its Total Current Liabilities has fluctuated over the past 5 years, first declined by 15.74% in 2023, then spiked by 32.55% in 2025.
- Quarterly analysis of 5 years shows Dr Reddys Laboratories' Total Current Liabilities stood at $1.1 billion in 2021, then increased by 8.68% to $1.2 billion in 2022, then decreased by 15.74% to $1.0 billion in 2023, then rose by 10.34% to $1.2 billion in 2024, then surged by 32.55% to $1.5 billion in 2025.
- Its Total Current Liabilities stands at $1.5 billion for Q1 2025, versus $1.2 billion for Q1 2024 and $1.0 billion for Q1 2023.
